Table 3 Multivariate regression results of the SNOT-22, PEG-3 and PHQ-9 scores among CRS patients waiting for ESS, evaluating the impact of at least one chronic pulmonary comorbidity
SNOT-22 Score | PEG-3 | PHQ-9 | |||||||
|---|---|---|---|---|---|---|---|---|---|
Model Effect | Estimate | SE | P-Value | Estimate | SE | P-Value | Estimate | SE | P-Value |
Intercept | 18.3 | 4.5 | < 0.001 | 0.53 | 0.15 | < 0.001 | 1.03 | 0.17 | < 0.001 |
Gender | |||||||||
Female | 4.7 | 2.6 | 0.070 | 0.16 | 0.09 | 0.056 | −0.07 | 0.10 | 0.472 |
Male (Ref.) | |||||||||
Age | |||||||||
< 40 | 13.9 | 5.0 | 0.005 | 0.49 | 0.17 | 0.003 | 0.46 | 0.19 | 0.015 |
40–49 | 19.9 | 4.7 | < 0.001 | 0.47 | 0.16 | 0.003 | 0.52 | 0.18 | 0.003 |
50–59 | 13.5 | 4.4 | 0.002 | 0.48 | 0.15 | 0.001 | 0.39 | 0.17 | 0.020 |
60–69 | 12.9 | 4.4 | 0.003 | 0.21 | 0.15 | 0.150 | 0.16 | 0.17 | 0.358 |
70+ (Ref.) | |||||||||
Chronic Pulmonary Comorbidity | |||||||||
Yes | 8.1 | 2.7 | 0.002 | 0.14 | 0.09 | 0.127 | 0.20 | 0.11 | 0.065 |
No (ref.) | |||||||||
Other Comorbidity Count | |||||||||
0 (Ref.) | |||||||||
1 | 2.0 | 3.3 | 0.547 | 0.29 | 0.11 | 0.007 | 0.32 | 0.13 | 0.013 |
2 or more | 13.6 | 3.2 | < 0.001 | 0.64 | 0.11 | < 0.001 | 0.76 | 0.12 | < 0.001 |